Trial Profile
Clinical Trials Insight: 700052788
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 22 Jan 2010
Price :
$35
*
At a glance
- Drugs Influenza virus delta-NS1 vaccine (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions; Pharmacodynamics
- Sponsors AVIR Green Hills Biotechnology
- 13 Jan 2010 New trial record.